mitoxantrone has been researched along with Osteolysis in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Look, RM | 1 |
| Lim, SW | 1 |
| Waxman, AD | 1 |
| Gupta, PK | 1 |
| Fuerst, MM | 1 |
| Kusuanco, DA | 1 |
| Lawrence, GN | 1 |
| Giles, FJ | 1 |
1 other study available for mitoxantrone and Osteolysis
| Article | Year |
|---|---|
Technetium-99m sestamibi scanning in multiple myeloma stem cell transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dexamethasone; Dise | 1996 |